Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (251-260 of 1,622) with videos related to

Pageof 163
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2005
Chemosensitivity and chemoresistance testingMaurie Markman
Oncology (Williston Park, N.Y.)|May 11, 2006
Management of ovarian cancer. An impressive history of improvement in survival and quality of lifeMaurie Markman
Gynecologic Oncology|March 17, 2006
Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodesMaurie Markman
Cancer|February 28, 2006
Providing research participants with findings from completed cancer-related clinical trials: not quite as simple as it soundsMaurie Markman
Gynecologic Oncology|February 16, 2006
Palliative chemotherapy "near the end-of-life" in ovarian cancer: not necessarily "aggressive cure-oriented therapy"Maurie Markman
Cleveland Clinic Journal of Medicine|January 1, 1997
When and how to use serum tumor markers in clinical practiceM Markman
Cancer Investigation|January 1, 1996
Should cost be considered in the overall evaluation of phase II clinical trials of new antineoplastic therapies?M Markman
Cancer Treatment and Research|January 1, 1996
Intraperitoneal taxolM Markman
Oncology|May 15, 2008
Comorbidity as a focus of clinical cancer trials: an important unmet needMaurie Markman
Reviews on Recent Clinical Trials|May 14, 2008
Intraperitoneal chemotherapy as primary treatment of advanced ovarian cancer: efficacy, toxicity, and future directionsMaurie Markman
Pageof 163

Showing results (251-260 of 1,622) with videos related to

Sort By:
Pageof 163
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2005
Chemosensitivity and chemoresistance testingMaurie Markman
Oncology (Williston Park, N.Y.)|May 11, 2006
Management of ovarian cancer. An impressive history of improvement in survival and quality of lifeMaurie Markman
Gynecologic Oncology|March 17, 2006
Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodesMaurie Markman
Cancer|February 28, 2006
Providing research participants with findings from completed cancer-related clinical trials: not quite as simple as it soundsMaurie Markman
Gynecologic Oncology|February 16, 2006
Palliative chemotherapy "near the end-of-life" in ovarian cancer: not necessarily "aggressive cure-oriented therapy"Maurie Markman
Cleveland Clinic Journal of Medicine|January 1, 1997
When and how to use serum tumor markers in clinical practiceM Markman
Cancer Investigation|January 1, 1996
Should cost be considered in the overall evaluation of phase II clinical trials of new antineoplastic therapies?M Markman
Cancer Treatment and Research|January 1, 1996
Intraperitoneal taxolM Markman
Oncology|May 15, 2008
Comorbidity as a focus of clinical cancer trials: an important unmet needMaurie Markman
Reviews on Recent Clinical Trials|May 14, 2008
Intraperitoneal chemotherapy as primary treatment of advanced ovarian cancer: efficacy, toxicity, and future directionsMaurie Markman
Pageof 163